These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28840468)

  • 1. The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease.
    Sanz-Blasco S; Bordone MP; Damianich A; Gomez G; Bernardi MA; Isaja L; Taravini IR; Hanger DP; Avale ME; Gershanik OS; Ferrario JE
    Mol Neurobiol; 2018 Jun; 55(6):5125-5136. PubMed ID: 28840468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models.
    Ba M; Kong M; Ma G
    Drug Des Devel Ther; 2015; 9():199-206. PubMed ID: 25565773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia.
    Gomez G; Saborido MD; Bernardi MA; Gershanik OS; Taravini IR; Ferrario JE
    Neurosci Lett; 2018 Feb; 666():5-10. PubMed ID: 29241709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NR2B antagonist CP-101,606 inhibits NR2B phosphorylation at tyrosine-1472 and its interactions with Fyn in levodopa-induced dyskinesia rat model.
    Kong M; Ba M; Liu C; Zhang Y; Zhang H; Qiu H
    Behav Brain Res; 2015 Apr; 282():46-53. PubMed ID: 25576965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of striatal serotonin and L -amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model.
    Gil S; Park C; Lee J; Koh H
    Cell Mol Neurobiol; 2010 Aug; 30(6):817-25. PubMed ID: 20232137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model.
    Ba M; Kong M; Guan L; Yi M; Zhang H
    Oncotarget; 2016 Sep; 7(37):58802-58812. PubMed ID: 27613848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
    Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
    Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?
    Angelopoulou E; Paudel YN; Julian T; Shaikh MF; Piperi C
    Mol Neurobiol; 2021 Apr; 58(4):1372-1391. PubMed ID: 33175322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fyn knockdown prevents levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Bordone MP; Damianich A; Bernardi MA; Eidelman T; Sanz-Blasco S; Gershanik OS; Avale ME; Ferrario JE
    eNeuro; 2021 Jun; 8(4):. PubMed ID: 34099487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
    Frau R; Savoia P; Fanni S; Fiorentini C; Fidalgo C; Tronci E; Stancampiano R; Meloni M; Cannas A; Marrosu F; Bortolato M; Devoto P; Missale C; Carta M
    Exp Neurol; 2017 May; 291():1-7. PubMed ID: 28131725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease.
    Ryu YK; Park HY; Go J; Choi DH; Kim YH; Hwang JH; Noh JR; Lee TG; Lee CH; Kim KS
    Mol Neurobiol; 2018 Jul; 55(7):5715-5726. PubMed ID: 29039022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
    Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
    Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture Alleviates Levodopa-Induced Dyskinesia via Melanin-Concentrating Hormone in Pitx3-Deficient aphakia and 6-Hydroxydopamine-Lesioned Mice.
    Kim YK; Lee AR; Park H; Yoo J; Ahn S; Jeon SH; Kim J; Park HJ
    Mol Neurobiol; 2019 Apr; 56(4):2408-2423. PubMed ID: 30030752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Keber U; Klietz M; Carlsson T; Oertel WH; Weihe E; Schäfer MK; Höglinger GU; Depboylu C
    Neuroscience; 2015 Jul; 298():302-17. PubMed ID: 25892702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an animal model of Parkinson's disease.
    Park HY; Kang YM; Kang Y; Park TS; Ryu YK; Hwang JH; Kim YH; Chung BH; Nam KH; Kim MR; Lee CH; Han PL; Kim KS
    J Neurosci; 2014 Aug; 34(35):11744-53. PubMed ID: 25164669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treadmill Exercise Attenuates L-DOPA-Induced Dyskinesia and Increases Striatal Levels of Glial Cell-Derived Neurotrophic Factor (GDNF) in Hemiparkinsonian Mice.
    Speck AE; Schamne MG; S Aguiar A; Cunha RA; Prediger RD
    Mol Neurobiol; 2019 Apr; 56(4):2944-2951. PubMed ID: 30073506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.
    Ahmed MR; Bychkov E; Kook S; Zurkovsky L; Dalby KN; Gurevich EV
    Exp Neurol; 2015 Apr; 266():42-54. PubMed ID: 25687550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats.
    Song L; Zhang Z; Hu R; Cheng J; Li L; Fan Q; Wu N; Gan J; Zhou M; Liu Z
    Drug Des Devel Ther; 2016; 10():547-55. PubMed ID: 26893543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression.
    Feyder M; Södersten E; Santini E; Vialou V; LaPlant Q; Watts EL; Spigolon G; Hansen K; Caboche J; Nestler EJ; Fisone G
    Biol Psychiatry; 2016 Mar; 79(5):362-371. PubMed ID: 25193242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.
    Wang Y; Wang HS; Wang T; Huang C; Liu J
    J Neurosci Res; 2014 Dec; 92(12):1733-45. PubMed ID: 24975553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.